Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a post-merger specialty pharmaceutical company focused on developing and commercializing non-opioid pain management therapeutics. The company reached public markets through its business combination with Denali Capital Acquisition Corp., a blank-check vehicle sponsored by Denali Capital that completed its SPAC IPO in 2021, with the de-SPAC merger closing in late 2022. Scilex operates in the healthcare and specialty pharma sector and has traded under the SCLX ticker since the transaction closed. The company filed a current report on Form 8-K with the SEC on July 22, 2026. For complete filing history, deal analytics, and ongoing SCLX coverage, sign up for full data access at SpacDesk.